These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
419 related items for PubMed ID: 28958949
1. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps. Azimi L, Rastegar Lari A. Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949 [Abstract] [Full Text] [Related]
2. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran. Talebi-Taher M, Majidpour َ, Gholami A, Rasouli-Kouhi S, Adabi M. J Infect Dev Ctries; 2016 Jun 30; 10(6):600-4. PubMed ID: 27367008 [Abstract] [Full Text] [Related]
3. Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran. Bijari A, Azimi L, Fallah F, Ardebili A, Lari ER, Lari AR. Infect Disord Drug Targets; 2016 Jun 30; 16(3):172-177. PubMed ID: 27572250 [Abstract] [Full Text] [Related]
4. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM. Arch Iran Med; 2015 Feb 30; 18(2):102-8. PubMed ID: 25644798 [Abstract] [Full Text] [Related]
5. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa. Goli HR, Nahaei MR, Rezaee MA, Hasani A, Kafil HS, Aghazadeh M, Nikbakht M, Khalili Y. J Infect Public Health; 2018 Feb 30; 11(3):364-372. PubMed ID: 28993173 [Abstract] [Full Text] [Related]
7. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C. J Antimicrob Chemother; 2008 Aug 30; 62(2):316-23. PubMed ID: 18467306 [Abstract] [Full Text] [Related]
8. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran. Goli HR, Nahaei MR, Rezaee MA, Hasani A, Samadi Kafil H, Aghazadeh M, Sheikhalizadeh V. Infect Genet Evol; 2016 Nov 30; 45():75-82. PubMed ID: 27562333 [Abstract] [Full Text] [Related]
9. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C. Antimicrob Agents Chemother; 2009 May 30; 53(5):1987-97. PubMed ID: 19258280 [Abstract] [Full Text] [Related]
10. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A, GERPA Study Group. J Antimicrob Chemother; 2013 Aug 30; 68(8):1763-71. PubMed ID: 23629014 [Abstract] [Full Text] [Related]
11. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment. Shen JL, Fang YP. Genet Mol Res; 2015 Jun 18; 14(2):6723-32. PubMed ID: 26125881 [Abstract] [Full Text] [Related]
12. RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA. Azimi L, Namvar AE, Jamali S, Lari AR, Bijari A, Lari AR. Roum Arch Microbiol Immunol; 2015 Jun 18; 74(3-4):86-90. PubMed ID: 27328522 [Abstract] [Full Text] [Related]
13. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa. Stratton CW, Weeks LS, Tausk F. J Antimicrob Chemother; 1987 Jan 18; 19(1):21-5. PubMed ID: 3104276 [Abstract] [Full Text] [Related]
14. [Investigation of acquired drug-resistant genes and strains relationship in Pseudomonas aeruginosa isolated from burn patients]. Fan YF, Cui SY, Zhang C, Xu XM. Zhonghua Shao Shang Za Zhi; 2018 Feb 20; 34(2):83-87. PubMed ID: 29973025 [Abstract] [Full Text] [Related]
15. Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of Pseudomonas aeruginosa in the North of Iran. Ahmadian L, Norouzi Bazgir Z, Ahanjan M, Valadan R, Goli HR. Biomed Res Int; 2021 Feb 20; 2021():7077344. PubMed ID: 34471641 [Abstract] [Full Text] [Related]
16. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams. Lerner SA, Quinn JP. Chemioterapia; 1985 Feb 20; 4(1):95-101. PubMed ID: 3921267 [Abstract] [Full Text] [Related]
17. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps. Ong CT, Tessier PR, Li C, Nightingale CH, Nicolau DP. Diagn Microbiol Infect Dis; 2007 Feb 20; 57(2):153-61. PubMed ID: 16930925 [Abstract] [Full Text] [Related]
18. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream. Najar Peerayeh S, Pirhajati Mahabadi R, Pakbaten Toupkanlou S, Siadat SD. Burns; 2014 Nov 20; 40(7):1360-4. PubMed ID: 24513132 [Abstract] [Full Text] [Related]
19. In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics. Wu DH, Baltch AL, Smith RP. Antimicrob Agents Chemother; 1984 Apr 20; 25(4):488-90. PubMed ID: 6428308 [Abstract] [Full Text] [Related]
20. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital]. Ronco E, Vacheron F, Orabona A. Pathol Biol (Paris); 1987 May 20; 35(5):558-62. PubMed ID: 3112708 [Abstract] [Full Text] [Related] Page: [Next] [New Search]